Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 25Myelodysplastic Syndromes 7Myeloproliferative Disorders 5Leukemia, Myelomonocytic, Chronic 3Thrombocythemia, Essential 1Recurrence 1Primary Myelofibrosis 1Polycythemia Vera 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia 1

Interventions

Cytarabine 3Injections 2Idarubicin 2Gemtuzumab 2Filgrastim 2Decitabine 2veliparib 1fludarabine phosphate 1aldesleukin 1Whole-Body Irradiation 1Temozolomide 1Peripheral Blood Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Daunorubicin 1CPX-351 1Busulfan 1Bone Marrow Transplantation 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myelomonocytic, Acute × CPX-351 × 1 year × Clear all
NCT04668885 2025-07-15

CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS

Case Comprehensive Cancer Center

Phase 2 Active not recruiting
13 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡